Sign in
Taking people in United StatesNo phase

Studies pituitary and hypothalamic tumors and related disorders in people

Studies pituitary gland tumors and related disorders, using tissue samples and MRI scans.

Key facts

Who runs it
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Where
Bethesda, United StatesSee the site
Trial code
Registry title
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
Status
Recruiting
People taking part
2,000 people, planned
Started
21 Apr 1997
Type of study
Observational
Treatments tested
  • Tissue specimen collection
  • MRI
Record updated
19 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people aged 2 to 70 with a tumor of the pituitary gland or the nearby hypothalamus, or a related disorder. Family members of such patients can also join.

Age
2 to 70 years for patients with a tumor. Family members can be any age.
Sex
All sexes can join.
Disease stage
A tumor of the hypothalamic-pituitary area or a related disorder, shown by earlier scans or hormone tests.

Main reasons for not taking part

  • Pregnancy
  • Any medical, physical, psychiatric or social condition that the investigators think makes joining not in the person's interest
  • Being critically ill, unstable, or having severe organ failure that limits the hormone tests

The registry criteria, word for word

Show all 8 criteriaShow less

Who cannot take part

  • Patients with any medical, physical, psychiatric, or social condition, which, in the opinion of the investigators, would make participation in this protocol not in their best interest, will be excluded from the study
  • Patients who are critically ill, unstable, or with severe organ failure that may affect/limit the endocrine evaluation and place unsustainable demands on CC or NICHD resources may be excluded
  • Pregnancy: Pregnancy will be evaluated only in participants of reproductive age (from 10 years old until 60 years of age unless menopause has already occurred per clinical report of the participant); For participants enrolled as external participants or under the Linkage study (where research activities include no more than blood draws), any female who could possibly become pregnant will be screened using clinical criteria (history, with pregnancy testing only if indicated) for exclusion and this information will be documented in the consent process note in EMR. If a participant has initially been registered as external location and then presents on-site, then pregnancy test will be performed if within the reproductive age group
  • An individual who meets any of the following criteria will be excluded from participation in this study:

Other criteria

  • INCLUSION CRITERIA:; In order to be eligible to participate in this study, an individual must meet all of the following criteria:
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Male or female with:; Evidence for the existence of a tumor of the hypothalamic-pituitary unit or related disorder, as indicated by previously obtained imaging studies or biochemical investigation of the hypothalamo-hypophyseal function (aged 2 years to 70 years); or; Family members (any age) of patients with a family history of tumors of the hypothalamic-pituitary unit or related disorders as part of the linkage part of the study, or; Members (any age) of a kindred suspected of having an inherited form of neoplasia of the hypothalamic-pituitary unit or related disorder, as evidenced by results of a patient enrolled in this protocol, as part of the linkage part of the study
  • Ability of the subject or LAR to understand and the willingness to sign a written informed consent document

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 2 and 70 years old?

Where in United States

  • National Institutes of Health Clinical CenterBethesda, United StatesContact: Ka Wing J LamTaking people

About the trial

What the trial wants to find out

There is a variety of tumors affecting the pituitary gland in childhood; some of these tumors (eg craniopharyngioma) are included among the most common central nervous system tumors in childhood. The gene(s) involved in the pathogenesis of these tumors are largely not known; their possible association with other developmental defects or inheritance pattern(s) has not been investigated. The present study serves as a (i) screening/training, and, (ii) a research protocol.

Read full original descriptionShow less

As a screening and training study, this protocol allows our Institute to admit children with tumors of the hypothalamic-pituitary unit to the pediatric endocrine clinics and wards of the NIH Clinical Center for the purposes of

(i) training our fellows and students in the identification of genetic defects associated with pituitary tumor formation, and

(ii) teaching our fellows and students the recognition, management and complications of pituitary tumors

As a research study, this protocol aims at

(i) developing new clinical studies for the recognition and therapy of pituitary tumors; as an example, two new studies have emerged within the context of this protocol: (a) investigation of a new research magnetic resonance imaging (MRI) tool and its usefulness in the identification of pituitary tumors, and (b) investigation of the psychological effects of cortisol secretion in pediatric patients with Cushing disease. Continuation of this protocol will eventually lead to new, separate protocols that will address all aspects of diagnosis of pituitary tumors and their therapy in childhood.

(ii) Identifying the genetic components of pituitary oncogenesis; those will be investigated by (a) studying the inheritance pattern of pituitary tumors in childhood and their possible association with other conditions in the families of the patients, and (ii) collecting tumor tissues and examining their molecular genetics. As with the clinical studies, the present protocol may help generate ideas for future studies on the treatment and clinical follow up of pediatric patients with tumors of the pituitary gland and, thus, lead to the development of better therapeutic regimens for these neoplasms.

The group in the trial

  • Patients with pituitary tumors or hypothalmic defects

    Treatment: Tissue specimen collection and MRI

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Clinical and Genetic Investigation of Pituitary and Hypothalamic Tumors and Related Disorders
Plain-language title
Studies pituitary and hypothalamic tumors and related disorders in peopleGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT00001595, who can take part
Publications
Record updated
19 October 2026